Insulet (PODD) Non Operating Income (2010 - 2026)
Insulet (PODD) reported Non Operating Income of $700000.0 for Q1 2026, up 131.82% on a YoY basis from $301960.8 in Q1 2025, and down 77.42% quarter-over-quarter from $3.1 million in Q4 2025.
Insulet (PODD) Non Operating Income (2010 - 2026) Analysis & Trends
Insulet has reported Non Operating Income for 17 years, with the latest figure at $700000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 131.82% year-over-year to $700000.0; the trailing twelve-month figure through Mar 2026 stood at $17.2 million (up 345.71% YoY), and the FY2025 full-year result was $14.3 million, up 360.0% from the prior year.
- Non Operating Income for Q1 2026 stood at $700000.0, down from $3.1 million in the prior quarter.
- The five-year high for Non Operating Income was $12.1 million in Q3 2025, with the low at -$3.4 million in Q3 2024.
- Historically, Non Operating Income has averaged $623529.4 across 5 years, with a median of $300000.0 in 2022.
- Annual changes were most pronounced in 2024 — Non Operating Income plunged 800.0% — and 2025, when it surged 675.0%.
- Insulet's Non Operating Income stood at $1.5 million in 2022, then increased by 26.67% to $1.9 million in 2023, then slumped by 78.95% to $400000.0 in 2024, then surged by 675.0% to $3.1 million in 2025, then plunged by 77.42% to $700000.0 in 2026.
- The last three Non Operating Income figures came in at $700000.0 (Q1 2026), $3.1 million (Q4 2025), and $12.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 159.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 121.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 61.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 71.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -55.03 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 14.20 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 36.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.80 Mn |
| 10 | Insulet | 10.20 Bn | 9.72 Bn | 529.10 Mn | 700,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 700,000.00 |
| Dec 31, 2025 | 3.10 Mn |
| Sep 30, 2025 | 12.10 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | -2.20 Mn |
| Dec 31, 2024 | 400,000.00 |
| Sep 30, 2024 | -3.40 Mn |
| Jun 30, 2024 | -1.80 Mn |
| Mar 31, 2024 | -700,000.00 |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | 700,000.00 |
| Jun 30, 2023 | -200,000.00 |
| Mar 31, 2023 | -200,000.00 |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | -1.80 Mn |
| Jun 30, 2022 | -1.10 Mn |
| Mar 31, 2022 | 300,000.00 |
| Dec 31, 2021 | -400,000.00 |
| Sep 30, 2021 | -700,000.00 |
| Jun 30, 2021 | 1.80 Mn |